Autism [MIM 209850] is a neurodevelopmental disorder exhibiting a complex genetic etiology with clinical and locus heterogeneity. Chromosome 15q11-q13 has been proposed to harbor a gene for autism susceptibility based on (1) maternal-specific chromosomal duplications seen in autism and (2) positive evidence for linkage disequilibrium (LD) at 15q markers in chromosomally normal autism families. To investigate and localize a potential susceptibility variant, we developed a dense single nucleotide polymorphism (SNP) map of the maternal expression domain in proximal 15q. We analyzed 29 SNPs spanning the two known imprinted, maternally expressed genes in the interval (UBE3A and ATP10C) and putative imprinting control regions. With a marker coverage of 1/10 kb in coding regions and 1/15 kb in large 5 0 introns, this map was employed to thoroughly dissect LD in autism families. Two SNPs within ATP10C demonstrated evidence for preferential allelic transmission to affected offspring. The signal detected at these SNPs was stronger in singleton families, and an adjacent SNP demonstrated transmission distortion in this subset. All SNPs showing allelic association lie within islands of sequence homology between human and mouse genomes that may be part of an ancestral haplotype containing a functional susceptibility allele. The region was further explored for recombination hot spots and haplotype blocks to evaluate haplotype transmission. Five haplotype blocks were defined within this region. One haplotype within ATP10C displayed suggestive evidence for preferential transmission. Interpretation of these data will require replication across data sets, evaluation of potential functional effects of associated alleles, and a thorough assessment of haplotype transmission within ATP10C and neighboring genes. Nevertheless, these findings are consistent with the presence of an autism susceptibility locus in 15q11-q13.
Introduction
Autism (MIM 209850) is a neurodevelopmental disorder affecting B1/1000 children with a male-tofemale ratio of 4 : 1. 1 Autism is characterized by traits and impairments in three core domains, including poor communication, limited social interaction, and repetitive and restricted behaviors and interests. Evidence from twin and family studies supports a strong genetic contribution, but suggests a complex etiology. [2] [3] [4] [5] [6] Chromosome 15q11-q13 has been a focus of genetic studies of autism susceptibility primarily because of the presence of cytogenetic abnormalities of this region in the autism population. Deficiencies of 15q11-q13 on the paternal or maternal chromosome result in Prader-Willi (PWS (MIM 176270)) or Angelman (AS (MIM 105830)) syndrome, respectively, because of the loss of expression of imprinted genes in the interval. 7, 8 Interstitial duplications of the same region are associated with increased risk for autism when maternally but not paternally derived. [9] [10] [11] [12] Supernumerary pseudodicentric marker chromosomes 15 (idic (15) ) of maternal origin confer two additional copies of the region and give rise to a more severe phenotype, [13] [14] [15] arguably stemming from a dosage effect. While these observations suggest that over-expression of an imprinted, maternally expressed gene(s) within 15q11-q13 drives autistic symptomatology associated with chromosomal duplications, it is unclear whether genes in the interval contribute to inherited susceptibility in chromosomally normal individuals.
The 15q11-q13 region consists of a large proximal domain (B2 Mb) of paternally-expressed genes, a smaller maternal expression domain (MED; B500 kb), and a large distal region (B2 Mb) of apparently biallelic expression (Figure 1a) . [16] [17] [18] Coordinate control of imprinted expression throughout the region is mediated by an imprinting center (IC) at the SNRPN promoter. 19, 20 While silencing of the maternal chromosome within the paternal expression domain is achieved or reinforced by extensive DNA methylation of the maternal allele, genes in the MED are seemingly not subject to differential methylation. 21 Repression of paternal transcripts in the MED has been speculated to involve a large antisense transcript originating from the SNRPN promoter, which may function as a repressor in cis. 20, 22 Based on the 15q duplication data, the autism candidate region in 15q11-q13 can be narrowed to an approximately 3 Mb interval, with a centromeric boundary defined by the IC and a telomeric border limited by the common telomeric duplication breakpoint ( Figure 1a ). The MED contains two known imprinted, maternally expressed genes, UBE3A and ATP10C. [23] [24] [25] [26] UBE3A is the causative gene in AS and encodes the E6-AP ubiquitin-protein ligase. 27 The ATP10C gene product is believed to function as an amphipathic phospholipid transporter that may be involved in CNS signaling. 26, 28 The telomeric, apparently nonimprinted, segment contains a cluster of GABA A receptor subunits (b3, a5, g3) and the OCA2 or P gene, which encodes a transporter involved in pigmentation. 29 Assuming that common gene(s) underlie disease risk in 15 duplication-associated autism and inherited susceptibility, a hypothetical susceptibility allele might arise from either parental homolog. Variants affecting the maternal allele might result in increased levels or activity of encoded proteins. Potential paternal variants could involve a relaxation of imprinted repression either generally or through 20 inappropriate temporal or spatial distributions. Alternatively, these two situations could involve distinct risk-related genes.
There have been mixed reports of linkage and LD in proximal 15q in autism families. One study reported modest evidence for linkage, 30, 31 and two others provided weak evidence, 32, 33 but an equal number of genomic screens failed to detect linkage to this region. [34] [35] [36] Three groups have observed LD at different markers within GABRB3; 30, [37] [38] [39] however, these findings were not replicated in three independent data sets. [40] [41] [42] Finally, we have recently reported allelic association in the Collaborative Linkage Study of Austism (CLSA) families at marker D15S122 located at the 5 0 end of UBE3A (42) . Based on this observation and the maternal specificity of 15q duplications, we targeted the MED for thorough investigation. We developed and analyzed a dense SNP map around UBE3A and ATP10C, and in key regions of imprinting control in order to measure association of individual marker and haplotype alleles in our data set (Figure 1b ).
Materials and methods

Families
The sample for this study consisted of 100 families, 42 affected sibling-pair (sib-pair) families and 58 trios. All affected sib-pair and 31 singleton families were recruited from the Tufts/New England Medical Center site of the CLSA group, while the remaining 27 trios were recruited through the University of Iowa CLSA site. The demographics of this sample have been described in detail previously; 32 the autism families in this data set are 98% Caucasian. All probands were at least four years of age and were clinically assessed with the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observation Schedule (ADOS). The mean ADI algorithm scores for the probands were 19.5476.05, 14.8275.20 and 5.1172.14 for domains 1 (social), 2 (communication) and 3 (repetitive behaviors), respectively. The cutoff scores for these domains are 10 for social impairments (domain 1), 8 for communication for verbal and 7 for nonverbal subjects (domain 2) and 3 for repetitive/stereotyped behaviors (domain 3). Probands were excluded from the study if they had a known medical or neurological condition suspected to be associated with their autistic phenotype (eg fragile X syndrome). The study was undertaken after Institutional Review Board review and approval, and all families provided written informed consent for participation in this study.
Molecular analysis
DNA was isolated from peripheral blood or lymphoblastoid cells using the PureGene kit according to the manufacturer's recommendations (Gentra Systems, Minneapolis, MN, USA). SNPs were selected from the dbSNP and Celera SNP databases based on their map position. Database reference numbers for SNPs are cited in Table 1 . PCR assays were developed and optimized to amplify a 100-1000 bp region flanking individual or pairs of SNPs (Table 2) . SNP authenticity was validated on a panel of 10-20 individual control samples. Putative SNPs that did not prove polymorphic were discarded. Individual SNPs were genotyped either by allele-specific oligonucleotide hybridization (ASO), pyrosequencing analysis (PSQ), or fluorescent polarization-template-directed dye terminator incorporation assay (FP-TDI) as indicated in Table 2 .
For ASO genotyping, PCR was performed in 20 ml reaction volumes utilizing 20 ng genomic DNA template, 1.0 mM primers, and Platinum Taq Master mix according to the manufacturer's recommendations (Life Technologies, Gaithersberg, MD, USA). Cycling conditions included an initial denaturation at 941C for 2 min, followed by 35 cycles of 941C for 15 s, optimal annealing temperature for 30 s, and 721C for 30 s, and a final extension at 721C for 10 min. The PCR product was denatured, spotted on duplicate nylon filters, and hybridized with radiolabeled allele-specific oligonucleotide probes by standard techniques. 43 For PSQ and FP-TDI genotyping, PCR reaction volumes were reduced to 10 ml, employing 20 ng genomic DNA template, 0.2 mM primers, 125 mM dNTPs and Applied Biosystems AmpliTaq Gold DNA polymerase and buffer (Applied Biosystems, Foster City, CA, USA). Cycling conditions included an initial denaturation at 951C for 10 min, followed by 50 cycles of 941C for 15 s, optimal annealing temperature for 30 s, and 721C for 15 s, and a final extension at 721C for 10 min. PSQ analysis was performed according to the manufacturer's recommended protocols (Pyrosequencing AB, Uppsala, Sweden) as described elsewhere. 44 FP-TDI analysis was performed using materials supplied in commercially available Acycloprime kits according to the manufacturer's published protocols (Perkin-Elmer Lifesciences, Boston, MA, USA) and as described elsewhere. 45 
Statistical analyses
Quality control checks consisted of initial verification of internal controls and assessment of Mendelian inconsistencies, followed by final haplotype consistency analyses using Simwalk2. 46 Conformity with anticipated Hardy-Weinberg equilibrium expectations was established, and SNPs were examined for intermarker LD using both the delta and D 0 measures calculated by the GOLD (graphical overview of linkage disequilibrium; 47 ) software package. LD in autism families was determined using the PDT and T SP statistics, modifications of the transmission disequilibrium test (TDT), which were developed for use with extended and sib-pair families. 48, 49 The T SP was used to determine parental-specific transmission separately for SNPs in ATP10C. Haplotype transmission was investigated by applying TRANSMIT to multiple adjacent markers. 50 Results were considered significant at the nominal level for markers or haplotypes with Po0.05. Case-control analyses, for comparison of allele frequencies between autism probands (one proband per family; n ¼ 160) and a CEPH comparison sample (n ¼ 82), were performed using Fisher's T-test. The CEPH sample represents an entirely Caucasian population of northern European ancestry. Visualization tools for alignment (VISTA) analysis was performed via web-based submission of human and mouse genomic sequence.
51,52
Results
We examined 29 markers across B1 Mb of sequence extending from SNRPN through ATP10C (Figure 1b ) in 100 autism families, consisting of 42 sib-pair and 58 singleton families. 23 SNPs were selected to construct a dense map across the transcriptional units of UBE3A and ATP10C, which together constitute the maternal expression domain (Table 1) . Six SNPs spanned the B100 kb UBE3A transcriptional unit and 17 SNPs spanned the B190 kb ATP10C transcriptional unit. SNPs were spaced to provide an average marker density of 1/10 kb across coding regions and 1/15 kb across large 5 0 introns. Two SNPs were chosen because of their proximity to the imprinting center, and four others because of their position within the presumed antisense transcript proposed to regulate the paternal imprint, one with the potential to affect methylation owing to the alteration of a CpG dinucleotide.
Genotypes at individual SNP loci did not deviate from expected predictions of Hardy-Weinberg equilibrium (data not shown). LD across the region was measured in our sample using the delta correlation and D 0 statistics available through the GOLD software package. Examination of intermarker LD relation reveals five haplotype blocks, one spanning the imprinting center/antisense region, one throughout the UBE3A transcriptional unit, and three within the ATP10C transcriptional unit (Figures 1b and 2 ). These blocks ranged in length from 5 to 165 kb. Haplotype frequencies and transmission patterns were assessed using TRANSMIT. Only 2-4 common haplotypes (present in greater than 10% of our families) existed for each block. In all instances, 80-95% of haplotypes could be differentiated by genotyping only 3-4 SNPs within a given block (Figure 3) . No common haplotypes showed significant evidence for preferential transmission in our data set; however, one three-SNP haplotype (SNPs 13-14-15) allele at the 3 0 end of ATP10C, which included an SNP showing allelic association individually, approached significance (P ¼ 0.05; Table 3 ). Less frequent haplotypes were not present at high enough frequencies to permit valid analysis.
Tests of transmission disequilibrium produced evidence for preferential transmission to affected offspring at a total of five SNPs within ATP10C. No evidence for association was found at SNPs or haplotypes within UBE3A or in the imprinting or antisense regions. In our initial analysis of the overall data set, two SNPs in ATP10C demonstrated association (Table 4) : a noncoding change in the first intron (SNP 24, P ¼ 0.03), and a synonymous substitution in the last coding exon (SNP 14, P ¼ 0.03). To further explore putative LD in ATP10C, we performed additional analyses of marker data for this gene. Two promoter region variations (SNP 27, P ¼ 0.03; SNP 28, P ¼ 0.03) yielded positive evidence when parental-specific transmissions were considered separately (Table 5 ). SNP 14 also demonstrated a maternal-specific effect, when paternal and maternal transmissions were considered separately.
Since our sample represented a mixed population of multiplex and singleton families, and because it is conceivable that different genetic mechanisms might underlie these subtypes, we measured the contribution of each group to the overall data (Table 5) . When the same data were analyzed only in the simplex families, SNP 14 showed increased significance (P ¼ 0.012) with a strong maternal transmission bias (P ¼ 0.008). Marker SNP 25 that was nonsignificant in the overall data set, showed a relatively strong association in trio families (P ¼ 0.007), with the significance also deriving from maternal transmissions (P ¼ 0.005).
Comparison of allele frequencies between autism cases (one proband/family) and a CEPH comparison sample showed a significant difference at two SNPs within ATP10C (Table 5) . The rare allele of SNP 24, which also showed preferential transmission to affected offspring, was more common in autism probands (P ¼ 0.019). A rare allele at SNP 17 was less common in autism (P ¼ 0.003).
We performed VISTA alignments of human and mouse genomic sequence throughout the region in order to determine whether these SNPs mapped to regions of preserved homology. All five SNPs map to regions of 475% homology (Figure 4 ).
Discussion
Theoretical modeling predictions and recent empirical studies indicate that association studies of SNPs and haplotypes may be optimally suited to the discovery of susceptibility genes conferring moderate risk for complex disease. [53] [54] [55] Autism, a complex genetic disorder thought to result from the interactions of multiple genes of low to moderate risk, is an ideal challenge for such an approach. Simulation and experimental data suggest that a dense SNP map will be necessary to detect and localize a susceptibility variant. [56] [57] [58] [59] This study provides comparatively dense marker coverage across the genes constituting the maternal expression domain of 15q11-q13, an attractive candidate region based on the maternal specificity of 15q duplications in autism.
This report demonstrates suggestive evidence of association at several markers within ATP10C. Since the two noncoding SNPs showing nominally significant effects lie within regions of evolutionary conservation, they could conceivably have functional effects. More likely, this result represents the potential detection of an indirect effect, the identification of markers that are not directly involved in disease risk but are in LD with another variant in ATP10C conferring disease risk. Alternatively, allelic effects detected at ATP10C could reflect association of alleles at a nearby gene, such as GABRB3, Although we would not a priori expect LD to persist across the 500 kb interval between ATP10C and a hypothetical Figure 3 Common haplotypes in the 15q11-q13 maternal expression domain. For the ATP10C 5 0 haplotype block, 80% of haplotypes are differentiated by genotypes at the four SNPs indicated. For the ATP10C 3 0 block, 80% of haplotypes are distinguished by genotypes at the three SNPs specified. For the UBE3A block, genotypes at the three SNPs shown differentiate 90% of haplotypes. If the shaded SNP is included, 95% of haplotypes can be discriminated. For the imprinting center/antisense block, 85% of haplotypes are differentiated by genotypes at three SNPs, or 90% by also including the shaded SNP. Haplotype allele frequencies are shown on the right. disease associated variant at GABRB3, there are reports of effects that persist hundreds of kilobases from a presumed susceptibility allele. 55, 60 Finally, although observations of transmission disequilibrium at multiple SNPs within the same gene argue against type I error, these data have not been corrected for multiple comparisons. Since appropriate methods for correction are currently unavailable for nonindependent comparisons as with markers in LD, ultimate interpretation will rely heavily on independent replication and further genetic analysis of ATP10C.
This report also describes patterns of intermarker LD in 15q11-q13 and defines corresponding haplotype blocks across the maternal expression domain. While tests for transmission distortion of haplotypes revealed no significant evidence for association, an important limitation to this study relates to the frequency of individual haplotypes and the number of observed transmissions in the current data set. Unless a particular haplotype was relatively common and had a comparatively large effect, our ability to detect association would be limited. If a hypothetical associated haplotype has a relatively small frequency (eg 10-15%), a very large data set would be required to permit observation of a sufficient number of transmissions to detect deviation from the null hypothesis of no association.
The application of VISTA for defining regions containing substantial cross-species homology is potentially an important tool for identification of functionally significant sequences in noncoding regions. Targeting conserved noncoding sequences could be a useful strategy in the selection of markers for allelic association studies. By insuring that such potentially functional sequences are represented by genetic markers, the opportunity for detecting a disease-associated effect attributable to variation in a hypothetical distant regulatory region is increased. However, given the density of SNPs tested here and their identification from ''normal'' genomic sequence, it is relatively unlikely that a functional SNP representing a putative risk-related variant would be selected by chance.
ATP10C exhibits imprinted, maternal expression within brain and appears to be expressed during brain development (E Nurmi, unpublished). Based on map position, expression profile, and LD data reported here, ATP10C remains an interesting candidate for autism susceptibility in 15q. Although an earlier report by Kim et al 6 found no evidence of association at 14 markers within ATP10C, a difference in the method of SNP selection may account for somewhat different results in this instance. Kim screened exons in a subset of their autism sample to identify the SNPs used in their overall analyses, while we relied upon SNPs annotated in genomic databases. Advantages to the screening strategy are that SNPs mapping within exons and present in an autism population are more likely to be directly involved in disease risk, and that rare mutations not detectable using allelic association methods can be identified. A drawback, however, is that SNP positions are dictated by the presence of SNPs in the screened portion of a particular sample. By representing all genomic regions and including SNPs within noncoding regions that are generally present at higher frequencies, there may be more opportunities to detect transmission distortion. One SNP was tested by both groups (SNP 14) but yielded nominally significant association in our data set and no association in the families analyzed by Kim et al, although any correction for multiple comparisons in the current report would similarly render the nominal association nonsignificant. The disparity between studies may be because of variations in the prevalence of a true susceptibility allele in the two samples owing to population differences or the nature of the families (sib-pairs and trios vs solely trios). Finally, these studies seek to identify a single gene of main effect. Given the proposed oligogenic inheritance in autism and the opportunity for gene-gene interactions, variability across studies would be consistent with allele(s) at another locus or loci influencing the effects of an allele or haplotype at this locus. Evidence of LD in this region has been historically variable across samples, and may relate to the genetic complexity of both the disorder and the genomic region. In summary, our observations of LD at multiple markers within ATP10C support the presence of an autism susceptibility allele in 15q11-q13. These data warrant further analysis, including replication in other data sets, an augmented SNP map, further exploration of haplotype structure in and around ATP10C, and evaluation of possible imprinting effects Figure 4 SNPs demonstrating transmission disequilibrium lie within evolutionarily conserved regions. VISTA output for relevant regions of ATP10C genomic sequence is shown. Gene annotations are provided above the graphs. Peaks indicate regions of homology between human and mouse genomic sequence. Peaks achieving greater than 75% homology are shaded; light purple or blue denotes coding exons and pink noncoding/intronic conserved sequence. Positions of exons are illustrated by shaded boxes above the sequence plots. Map location of SNPs yielding evidence for association with autism are highlighted by arrowheads and labeled accordingly.
that may add further complexity to this story. The significance of current findings in light of our previous observation of LD at D15S122 immediately telomeric/5 0 to UBE3A is not entirely clear. D15S122 is in a distinct haplotype block from SNPs showing association at ATP10C. These results may suggest that more than one allele from this region confers risk for autism, or the previous result could represent a falsepositive finding. Most studies testing for LD in this region using microsatellite markers did not include D15S122, so comparison across studies is limited.
Much recent discussion and speculation has centered on optimal strategies for SNP selection in candidate gene and whole genome association studies. [57] [58] [59] 62 Although there is enthusiasm for the implementation of a dense SNP map to adequately represent a gene or genome, there is much debate among supporters regarding the nature of the SNPs that should define that map. 54, 56, 57, 63 It has been proposed that a more economical and efficient approach would focus on polymorphisms of sufficient frequency that are in a position to confer functional effects on a gene. 54, 63 For coding sequence, splice sites, and even promoter regions, it might be feasible to predict 'functional' SNPs; however, deep intronic or intergenic regulatory regions would not be represented by this strategy. The ability to prioritize potentially functional components of noncoding sequence using cross-species sequence homology may enable the inclusion of regions that could conceivably harbor the more subtle variations that may underlie susceptibility to complex genetic disease. 
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